BIOA CLASS ACTION UPDATE: BioAge Labs Investors are Reminded to Contact BFA Law before Imminent March 10 Deadline
In truth, BioAge was forced to discontinue the STRIDES Phase 2 trial after several subjects exhibited elevated liver enzyme levels, indicating potential organ damage. Consequently, the Company ...
BioSpace1h
Explainer: The Thriving Shadow Market of GLP-1s for Weight Loss
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
Lilly Profit View ‘Enough to Pacify Investors’ After Sales Miss
Eli Lilly & Co.’s full-year earnings forecast came in line with analysts’ estimates as the company works to fix inventory ...
Investing6d
Eli Lilly and Co BDR (LILY34)
By Dan Levine and Marisa Taylor (Reuters) - Eli Lilly (NYSE:LLY) and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after... Analysts from BMO ...